Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective

BACKGROUND: Cost-effectiveness of once-daily umeclidinium bromide (UMEC) was compared with once-daily tiotropium (TIO) and once-daily glycopyrronium (GLY) in patients with chronic obstructive pulmonary disease (COPD) from a UK National Health Service (NHS) perspective. METHODS: A linked-equation mod...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cost Eff Resour Alloc
Autors principals: Shah, Dhvani, Driessen, Maurice, Risebrough, Nancy, Baker, Timothy, Naya, Ian, Briggs, Andrew, Ismaila, Afisi S.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946544/
https://ncbi.nlm.nih.gov/pubmed/29773969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-018-0101-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars